Endpoints News 2026-02-04 AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira
Endpoints News 2026-02-04 Rare pediatric PRV program reauthorized until 2029 via government funding law
Endpoints News 2026-02-04 Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Endpoints News 2026-02-03 'Turning around the Titanic': How the incoming PBM reforms will transform CMS
Endpoints News 2026-02-03 Ultragenyx unwraps data that may be central to its gene therapy resubmission
Endpoints News 2026-02-03 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News 2026-02-03 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months